Related Experiment Video
Updated: Jul 20, 2025

Chromatographic Purification of Highly Active Yeast Ribosomes
Published on: October 24, 2011
Molecular basis of the pleiotropic effects by the antibiotic amikacin on the ribosome
Savannah M Seely1, Narayan P Parajuli2, Arindam De Tarafder2
1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Abstract:
Aminoglycosides are a class of antibiotics that bind to ribosomal RNA and exert pleiotropic effects on ribosome function. Amikacin, the semisynthetic derivative of kanamycin, is commonly used for treating severe infections with multidrug-resistant, aerobic Gram-negative bacteria. Amikacin carries the 4-amino-2-hydroxy butyrate (AHB) moiety at the N1 amino group of the central 2-deoxystreptamine (2-DOS) ring, which may confer amikacin a unique ribosome inhibition profile. Here we use in vitro fast kinetics combined with X-ray crystallography and cryo-EM to dissect the mechanisms of ribosome inhibition by amikacin and the parent compound, kanamycin. Amikacin interferes with tRNA translocation, release factor-mediated peptidyl-tRNA hydrolysis, and ribosome recycling, traits attributed to the additional interactions amikacin makes with the decoding center. The binding site in the large ribosomal subunit proximal to the 3'-end of tRNA in the peptidyl (P) site lays the groundwork for rational design of amikacin derivatives with improved antibacterial properties.
Insights
Amikacin, an aminoglycoside antibiotic, uniquely inhibits bacterial ribosome function by interfering with tRNA translocation and recycling. This detailed mechanism, revealed by crystallography and cryo-EM, aids in designing new antibiotics.
Area of Science:
- Molecular Biology
- Structural Biology
- Microbiology
Background:
- Aminoglycosides are crucial antibiotics targeting bacterial ribosomes.
- Amikacin, a kanamycin derivative, combats multidrug-resistant Gram-negative bacteria.
- Amikacin's unique structure, featuring a 4-amino-2-hydroxy butyrate (AHB) moiety, suggests distinct ribosome interaction mechanisms.
Purpose of the Study:
- To elucidate the precise mechanisms of ribosome inhibition by amikacin and kanamycin.
- To understand how amikacin's unique structural features influence its antibacterial activity.
- To identify potential targets for developing improved amikacin derivatives.
Main Methods:
- In vitro fast kinetics assays.
- X-ray crystallography.
- Cryo-electron microscopy (cryo-EM).
Main Results:
- Amikacin exhibits a distinct ribosome inhibition profile compared to kanamycin.
- Amikacin interferes with key ribosomal processes: tRNA translocation, peptidyl-tRNA hydrolysis, and ribosome recycling.
- Structural analysis reveals amikacin's additional interactions within the ribosomal decoding center.
Conclusions:
- Amikacin's enhanced ribosome inhibition stems from unique interactions mediated by its AHB moiety.
- The identified binding site in the large ribosomal subunit provides a basis for rational drug design.
- This research paves the way for developing novel aminoglycoside antibiotics with improved efficacy against resistant bacteria.
Related Concept Videos
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Improving Translational Accuracy
Coordination of Gene Expression Processes in Bacteria
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Leaky Scanning

